Immunoconjugates targeting CD138 and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9387261
APP PUB NO 20090232810A1
SERIAL NO

12342407

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are immunoconjugates having in particular specificity for CD138 expressed on target cells and which display homogenous targeting. The immunoconjugates may be sterially hindered and/or contain a cleavable linker.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNOGEN INC830 WINTER STREET WALTHAM MA 02451
BIOTEST AGLANDSTEINERSTR 5 DREIEICH 63303

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aigner, Silke Frankenthal, DE 12 163
Bruecher, Christoph Eschborn, DE 18 205
Daelken, Benjamin Frankfurt am Main, DE 24 227
Germer, Matthias Langen, DE 14 133
Haeder, Thomas Dreieich, DE 6 22
Kraus, Elmar Bad Vilbel, DE 11 170
Osterroth, Frank Dietzenbach, DE 18 194
Schulz, Gregor Umkirch, DE 13 85
Uherek, Christoph Seligenstadt, DE 26 302
Zeng, Steffen Muenster, DE 8 71

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 12, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 12, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00